US Patent Issued to Nanjing GenScript Biotech on July 15 for "Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use thereof" (Chinese, Singaporean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,987, issued on July 15, was assigned to Nanjing GenScript Biotech Co. Ltd. (Nanjing, China).

"Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use thereof" was invented by Liusong Yin (Nanjing, China), Zhongdao Li (Nanjing, China), Tielin Zhou (Singapore) and Zhuo Fang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-CD47/anti-PD-1 bispecific antibody, preparation method thereof and use thereof. The bispecific antibody includes (a) a first antigen binding portion including a heavy chain variable region (Vn) and a light chain variable region (Vl), wherein Vn and Vl form an antigen ...